10x Genomics (NASDAQ:TXG) stock slid 14% Wednesday amid news that Illumina (NASDAQ:ILMN) has acquired single cell analysis technology company Fluent BioSciences and a downgrade by Deutsche Bank. The ...

10x Genomics is up 7.5% since the beginning of the year, and at $15.26 per share, it is trading close to its 52-week high of $16.47 from December 2024. Investors who bought $1,000 worth of 10x ...

That occurred on Monday, when Tejas Savant from white-shoe investment bank Morgan Stanley reduced his 10x Genomics price target to $18 per share, far down from his previous level of $26. Despite that, ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 6.3% in the morning session after Citigroup downgraded the stock to Neutral from Buy. The analyst firm adjusted its rating on the life science ...

PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...